Bedah Benign Prostatic Hyperplasia

Embed Size (px)

Citation preview

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    1/27

    BENIGN PROSTATIC

    HYPERPLASIA (BPH)

    Dr. Nurul Akbar, Sp. U

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    2/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    3/27

    INCIDENCE  most common benign tumor in men

      its incidence is age-related

      symptoms of prostatic obstruction are also

    age-related (decrease in the force andcaliber of their urinary stream).

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    4/27

    EPIDEMIOLOGY  isk factors for the de!elopment of "#$ are

    poorly understood

      Some studies ha!e suggested a genetic

    predisposition, and some ha!e noted racialdifferences.

      Appro%imately &' of men under the age of '

    *ho undergo surgery for "#$ may ha!e a

    heritable form of the disease.

      +his form is most likely an autosomal dominant

    trait, and first-degree male relati!es of such

    patients carry an increased relati!e risk of

    appro%imately -fold.

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    5/27

    ETIOLOGY

      not completely understood

      multifactorial and endocrine controlled

      prostate is composed of both stromal and

    epithelial elements  "#$ is under endocrine control

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    6/27

    PATHOLOGY

      "#$ de!elops in the transition one

      t is truly a hyperplastic process resulting from an increase in

    cell number

      /icroscopic e!aluation re!eals a nodular gro*th pattern that

    is composed of !arying amounts of stroma and epithelium.  Stroma is composed of !arying amounts of collagen and

    smooth muscle

      alpha-blocker therapy may result in e%cellent responses in

    patients *ith "#$ that has a significant component of

    smooth muscle,  "#$ predominantly composed of epithelium might respond

    better to &-reductase inhibitors

      #atients *ith significant components of collagen in the

    stroma may not respond to either form of medical therapy

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    7/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    8/27

    PATHOPHYSIOLOGY  mechanical obstruction 0 intrusion into the

    urethral lumen or bladder neck, leading to a

    higher bladder outlet resistance

     

    Dynamic obstruction 0+he prostatic stroma,composed of smooth muscle and collagen, is

    rich in adrenergic ner!e supply. +he le!el of

    autonomic stimulation thus sets a tone to the

    prostatic urethra. Use of alpha-blockertherapy decreases this tone, resulting in a

    decrease in outlet resistance.

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    9/27

      +he irritati!e !oiding complaints 0 result

    from the secondary response of the bladder

    to the increased outlet resistance

     

    "ladder outlet obstruction leads to detrusormuscle hypertrophy and hyperplasia as *ell

    as collagen deposition (seen as trabeculation

    on cystoscopic e%amination)

     

    f left unchecked, mucosal herniationbet*een detrusor muscle bundles ensues,

    causing di!erticula formation

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    10/27

    SYMPTOMS  1bstructi!e 0 hesitancy, decreased force and

    caliber of stream, sensation of incomplete

    bladder emptying, double !oiding (urinating

    a second time *ithin 2 h of the pre!ious!oid), straining to urinate, and post-!oid

    dribbling.

      rritati!e 0 urgency (difficult to postpone

    urination), fre3uency (4 times per day),and nocturia (nocturnal fre3uency 42 times)

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    11/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    12/27

    IPSS  '56 0 mild 7U+S

      859: 0 moderate 7U+S

      2'5;& 0 se!ere 7U+S

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    13/27

    SIGNS

    D, transrectal ultrasound, andbiopsy).

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    14/27

    LABORATORY FINDINGS  urinalysis 0 e%clude infection or hematuria

      serum creatinine 0 to assess renal function

      Serum #SA

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    15/27

    IMAGING  intra!enous pyelogram or renal ultrasound

      recommended only in the presence of

    concomitant urinary tract disease or

    complications from "#$ (eg, hematuria,urinary tract infection, renal insufficiency,

    history of stone disease).

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    16/27

    ADDITIONAL TESTS  /easurement of flo* rate

      post-!oid residual urine

      urodynamic profiles 0 reser!ed for patients

    *ith suspected neurologic disease or those*ho ha!e failed prostate surgery

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    17/27

    DIFFERENTIAL DIAGNOSIS  urethral stricture

      bladder neck contracture

      bladder stone

      ?a#  urinary tract infection

      neurogenic bladder

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    18/27

    TREATMENT  *atchful *aiting

      /edical +herapy (alpha blocker and & A)

      surgical (recurrent urinary tract infection,

    hematuria, bladder stones, renalinsufficiency or large bladder di!erticula)

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    19/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    20/27

    CONVENTIONAL SRGICAL

    THERAPY  +ransurethral esection of the #rostate

    (+U#)

      +ransurethral ncision of the #rostate

     

    1pen Simple #rostatectomy

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    21/27

    MINIMALLY INVASIVE THERAPY  7aser +herapy

      +ransurethral

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    22/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    23/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    24/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    25/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    26/27

  • 8/17/2019 Bedah Benign Prostatic Hyperplasia

    27/27

    Smiths Beneral Urology

    +hank you